CONy 2025 at a glance

Get ready for CONy 2025 with LucidQuest’s expert preview. We highlight the key debates in clinical neurology along with emerging AI tools, helping you navigate the controversies that will shape practice in 2025.

📅 Build your schedule around the topics that interest you. 📥 Download the CONy 2025_Preview_by_LucidQuest

Dive deeper

Key Topics From CONy 2025 Scientific Presentations

Alzheimer’s Disease

Donanemab slows progression by 33.6%, targeting amyloid and tau accumulation.
The Mediterranean diet’s role in dementia prevention.

Multiple Sclerosis

Frexalimab reduces new lesions and lowers NfL levels in relapsing MS.
Emphasis on early diagnosis and better nutritional guidance.

Neuromyelitis Optica Spectrum Disorder / Myasthenia Gravis

Inebilizumab lowers attack rates in NMOSD.
Efgartigimod improves quality of life in generalized myasthenia gravis by reducing steroid dependence.

Epilepsy & Seizures

Gut microbiome changes and emotional disturbances linked to seizure exacerbations, paving the way for new therapies.

Stroke Research

Advanced imaging and thrombectomy sedation improve outcomes.
Thrombus pathology uncovers hidden stroke causes.

Neuroprotection

Antioxidants (e.g., lycopene) demonstrate neuroprotective effects.
Early detection and genetic testing are crucial for neuropathies like carpal tunnel syndrome and Charcot–Marie–Tooth disease.

Inflammatory Polyneuropathies

Riliprubart and efgartigimod reduce relapse risk.
Baicalin shows neuroprotective potential.

COQ8A Mutations

Early detection improves chronic polyneuropathy management, highlighting ALS overlap for further research.

Artificial Intelligence and Machine Learning in Neurology

AI-driven analysis outperforms traditional methods, enabling earlier dementia interventions.
Tele-rehabilitation and AI-generated stroke rehab plans enhance patient recovery.

📅 Build your schedule around the topics that interest you.

📥 Download the CONy 2025_Preview_by_LucidQuest

Contact us for end-to-end conference coverage.